Selling And Administration Expenses 更改
Alaunos Therapeutics USD 3.58M 533K 2023-09
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Heron Therapeutics USD 24.6M 11.84M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Intrexon USD 9.2M 120K 2023-09
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
MannKind USD 20.54M 3.44M 2023-12
Merck USD 2.75B 272M 2023-12
Peregrine Pharmaceuticals USD 6.56M 294K 2023-09
Rigel Pharmaceuticals USD 24.86M 1.45M 2023-09
Roche Holding CHF 6.51B 26M 2023-06
Thermo Fisher Scientific USD 1.67B 377M 2023-12
Veracyte USD 49.06M 9.55M 2023-12
Xencor USD 15.48M 2.98M 2023-12



Intrexon 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.